Rate My Professor Boaz Arzi

Boaz Arzi, DVM, DAVDC, DEVDC, FF-AVDC-OMFS, is a Professor in the Department of Surgical and Radiological Sciences at the University of California, Davis School of Veterinary Medicine. He earned his DVM in 2002 from the University of Szent Istvan, Faculty of Veterinary Medicine in Budapest, Hungary. Arzi is a Diplomate of both the American and European Veterinary Dental Colleges and a Founding Fellow in Oral and Maxillofacial Surgery of the American Veterinary Dental College. Currently serving as the Director of the Veterinary Institute for Regenerative Cures (VIRC), he has been instrumental in advancing clinical studies and education in regenerative therapies since the institute's inception. As a Professor of Dentistry and Oral Surgery, he leads efforts in translational research bridging veterinary and human medicine under the One Health initiative.

Arzi's research specializes in oral and maxillofacial regenerative medicine, tissue engineering, maxillofacial reconstruction, temporomandibular joint (TMJ) disorders, and veterinary dentistry. Key areas include mesenchymal stem cell therapies for feline chronic gingivostomatitis, biomechanical evaluations of mandibular fractures, and diagnostic imaging such as cone beam computed tomography. He serves as principal investigator or co-investigator on multiple grants, including NIH/NIDCR projects for TMJ disc regeneration, Foundation for Veterinary Dentistry study on cone beam CT and canine TMJ osteoarthritis, and Center for Companion Animal Health initiatives on PET/CT diagnostics and plating systems for fractures. Prominent publications encompass several chapters in the second edition of Oral and Maxillofacial Surgery in Dogs and Cats (2020), addressing maxillectomy techniques, clinical staging of maxillofacial tumors, TMJ ankylosis, pseudoankylosis, dysplasia, and fractures. Highly influential papers include "Companion animals: Translational scientist’s new best friends" (Science Translational Medicine, 2015), "Therapeutic efficacy of fresh, autologous mesenchymal stem cells for severe refractory gingivostomatitis in cats" (Stem Cells Translational Medicine, 2016), "Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis" (Stem Cells Translational Medicine, 2017), and "Tissue engineering toward temporomandibular joint disc regeneration" (Science Translational Medicine, 2018). With over 3,900 citations documented on ResearchGate, his contributions significantly impact regenerative therapies in companion animals. Arzi is a board member of the North American Veterinary Regenerative Medicine Association and delivers lectures at major veterinary surgery summits.